Gujarat Alkalies and Chemicals Limited (BOM:530001)
470.20
-10.75 (-2.24%)
At close: Feb 13, 2026
BOM:530001 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Revenue | 43,082 | 40,729 | 38,066 | 45,165 | 37,587 | 24,295 |
Revenue Growth (YoY) | 7.73% | 7.00% | -15.72% | 20.16% | 54.71% | -10.83% |
Cost of Revenue | 29,111 | 28,367 | 28,700 | 26,327 | 20,277 | 14,312 |
Gross Profit | 13,972 | 12,362 | 9,366 | 18,838 | 17,310 | 9,983 |
Selling, General & Admin | 4,514 | 3,682 | 3,228 | 2,989 | 3,114 | 2,630 |
Other Operating Expenses | 5,012 | 4,721 | 4,595 | 4,356 | 4,321 | 3,761 |
Operating Expenses | 13,598 | 12,326 | 11,597 | 10,106 | 9,413 | 8,142 |
Operating Income | 373.49 | 36.19 | -2,230 | 8,732 | 7,897 | 1,841 |
Interest Expense | -620.71 | -465.01 | -422.8 | -171.23 | -36.88 | -130.71 |
Interest & Investment Income | 517.54 | 517.54 | 752.67 | 380.99 | 361.33 | 604.7 |
Earnings From Equity Investments | -428.57 | -809.37 | -1,046 | -1,661 | -22.17 | -11.14 |
Currency Exchange Gain (Loss) | -100.21 | -100.21 | -71.27 | -344.37 | -5.13 | 38.87 |
Other Non Operating Income (Expenses) | 349.98 | 44.78 | -16.39 | -13.55 | -21.93 | -13.77 |
EBT Excluding Unusual Items | 91.52 | -776.08 | -3,034 | 6,923 | 8,172 | 2,329 |
Gain (Loss) on Sale of Investments | 51.56 | 51.56 | 30.13 | 29.01 | 96.26 | 20.86 |
Gain (Loss) on Sale of Assets | 12.38 | 12.38 | -0.7 | -0.68 | -4.09 | -3.2 |
Pretax Income | 155.46 | -712.14 | -3,005 | 6,951 | 8,264 | 2,347 |
Income Tax Expense | 241.15 | -60.95 | -636.34 | 2,855 | 2,666 | 689.53 |
Net Income | -85.69 | -651.19 | -2,368 | 4,096 | 5,598 | 1,657 |
Net Income to Common | -85.69 | -651.19 | -2,368 | 4,096 | 5,598 | 1,657 |
Net Income Growth | - | - | - | -26.82% | 237.74% | -50.09% |
Shares Outstanding (Basic) | 73 | 73 | 73 | 73 | 73 | 73 |
Shares Outstanding (Diluted) | 73 | 73 | 73 | 73 | 73 | 73 |
EPS (Basic) | -1.17 | -8.87 | -32.25 | 55.78 | 76.22 | 22.57 |
EPS (Diluted) | -1.17 | -8.87 | -32.25 | 55.78 | 76.22 | 22.57 |
EPS Growth | - | - | - | -26.82% | 237.73% | -50.09% |
Free Cash Flow | - | 557.34 | -1,646 | 2,769 | -1,739 | -3,729 |
Free Cash Flow Per Share | - | 7.59 | -22.42 | 37.71 | -23.68 | -50.78 |
Dividend Per Share | - | 15.800 | - | 23.550 | 10.000 | 8.000 |
Dividend Growth | - | - | - | 135.50% | 25.00% | - |
Gross Margin | 32.43% | 30.35% | 24.61% | 41.71% | 46.05% | 41.09% |
Operating Margin | 0.87% | 0.09% | -5.86% | 19.33% | 21.01% | 7.58% |
Profit Margin | -0.20% | -1.60% | -6.22% | 9.07% | 14.89% | 6.82% |
Free Cash Flow Margin | - | 1.37% | -4.32% | 6.13% | -4.63% | -15.35% |
EBITDA | 4,365 | 3,918 | 1,505 | 11,454 | 9,837 | 3,549 |
EBITDA Margin | 10.13% | 9.62% | 3.96% | 25.36% | 26.17% | 14.61% |
D&A For EBITDA | 3,991 | 3,882 | 3,736 | 2,723 | 1,940 | 1,707 |
EBIT | 373.49 | 36.19 | -2,230 | 8,732 | 7,897 | 1,841 |
EBIT Margin | 0.87% | 0.09% | -5.86% | 19.33% | 21.01% | 7.58% |
Effective Tax Rate | 155.12% | - | - | 41.07% | 32.27% | 29.38% |
Revenue as Reported | 44,309 | 41,650 | 38,967 | 45,587 | 38,051 | 24,969 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.